Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). (Q33444047)
scientific article
Language:
Current Data About Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
(P31) (Q13442814)
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P50) (Q63847562)
(P1545) 8
(P1932) M A Fischl
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P304) 76-81
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P407) (Q1860)

(P433) 8577
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P478) 1
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P577) Friday, January 1, 1988
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P921) (Q198504)
(P887)

(P1433) (Q939416)
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P1476) "Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT)." (language: en)
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

(P2093) R Yarchoan
(P1545) 1
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

C F Perno
(P1545) 2
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

R V Thomas
(P1545) 3
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

R W Klecker
(P1545) 4
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

J P Allain
(P1545) 5
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

R J Wills
(P1545) 6
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

N McAtee
(P1545) 7
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

R Dubinsky
(P1545) 9
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

M C McNeely
(P1545) 10
(P248)
(P698) 2891981
(P813) Wednesday, July 26, 2017

other details
description scientific article

External Links
(P356) 10.1016/S0140-6736(88)90283-8
(P698) 2891981